2019-09-30 |
1 |
Complaint |
of United States Patent Nos.7,045,620 (the
“’620 patent”); 7,612,199 (the “’199 patent”); 7,902,206 (the…infringed one or more claims of United States Patent
Nos. 7,045,620; 7,612,199; 7,902,206; 7,906,542; 7,915,275…infringe one or more
claims of United States Patent Nos. 7,045,620; 7,612,199; 7,902,206; 7,906,542; 7,915,… C. A judgment that United States Patent Nos. 7,045,620; 7,612,199; 7,902,206;
7,906,542; 7,915,275…to the expiration date of United States Patent Nos. 7,045,620; 7,612,199; 7,902,206; 7,906,542;
7,915,275 |
External link to document |
2019-12-16 |
15 |
Amended Complaint |
the
“’231 patent”); 9,271,968 (the “’968 patent”); and 10,456,384 (the “’384 patent”) (collectively,
…8,741,904; 8,835,452; 8,853,231; 9,271,968; and 10,456,384 by
submitting ANDA No. 213713 seeking FDA approval…8,741,904; 8,835,452; 8,853,231;
9,271,968; and 10,456,384 under 35 U.S.C. §§ 271(a), (b), (c), and/or (…8,741,904;
8,835,452; 8,853,231; 9,271,968; and 10,456,384 remain valid and enforceable;
…8,741,904; 8,835,452;
8,853,231; 9,271,968; and 10,456,384, inclusive of any exclusivities and extensions |
External link to document |